Health and Medical News - Page 32

Page 32 of Health and Medical News issued by the Send2Press® Newswire service.



Phase I Clinical Trial for Advanced Colon and Pancreatic Cancer Opens in New York Using Rexin-G, the World’s First Tumor-Targeted Gene Delivery Vector

LOS ANGELES, Calif. — (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation (www.epeiusbiotech.com) announced today that a Phase I clinical trial has opened in New York to test the safety and efficacy of Rexin-G, the leading tumor-targeted gene delivery system (vector) developed for the treatment of metastatic colon and pancreatic cancer. In 2003, Rexin-G gained FDA approval as an Orphan Drug based on clinical demonstrations of the medical utility of Rexin-G as an effective treatment for pancreatic cancer.

New York Eye Surgeon Chosen to Implant ReSTOR(R) Pseudoaccommodative Lens for Cataract Correction

POUGHKEEPSIE, NY /Send2Press Newswire/ — Satish. S. Modi, M.D., F.R.C.S. ( C ) a leading ophthalmic surgeon in Poughkeepsie, New York has been selected by Alcon Laboratories as one of a limited number of surgeons to begin implanting its AcrySoft(R) ReSTOR(R) Intraocular Lens (IOL) for cataract patients with and without presbyopia.

For Greater Northwest Medical Group The Future Is Now!

BUFFALO GROVE, IL /Send2Press Newswire/ — Greater Northwest Medical Group, including eleven Internal Medicine and Family Practice physicians, treating patients at its Buffalo Grove, Arlington Heights, and Park Ridge offices, announces its transition from traditional paper medical charts to Electronic Medical Records (EMR).

Dr. Barry J. Kaplan Published for Breast Augmentation Using Only Local Anesthesia

WINTER PARK, FL /Send2Press Newswire/ — Kaplan Cosmetic Surgery, Inc. is pleased to announce that its founder and director, Barry J. Kaplan, D.O., was published in the June 2004 issue of the Journal of the American Academy of Cosmetic Surgery for an original article.

Global Medical Research Announces Breakthrough Technology to Prevent Post-Surgical Adhesions

ORLANDO, FL /Send2Press Newswire/ — Global Medical Research, LLC (www.gmrllc.com), a Central Florida-based company dedicated to developing and commercializing intellectual properties that address problems in the biomedical field, today announced the launch of breakthrough technology designed to prevent post surgical adhesions. GMR’s Internal-Tissue Engineered Membrane Product (i-TEMP(tm)), is now poised for advanced phase animal testing to support the expectations of a broad spectrum of uses.

Novel Patented Technology Enables Low Cost, Instant Ultraviolet Disinfection for Home and Personal Care Products

BOSTON, MA /Send2Press Newswire/ — Ultraviolet disinfection technology developed for hospital-use now available for a number of home and personal care products such as toothbrushes, pacifiers, drinking cups, knives, cutting boards, etc. reports UVSolutions, LLC (www.uvs-ultraclean.com).

Sprixx Announces New Unscented Formula for Wearable Hand Sanitizer

SANTA BARBARA, Calif. /Send2Press Newswire/ — Sprixx (www.sprixx.com), a DBA of Harbor Medical, Inc., has announced the availability of a new unscented alcohol hand sanitizer formula for its line of professional body-worn hand sanitizers. Containing 63% ethyl alcohol with emollients, the new product is available for the popular Sprixx XE Dispenser which is delivered in a 1.35-ounce replacement cartridge.

New FDA Approved Test Detects Thyroid Disease in Minutes

HONEY BROOK, PA /Send2Press Newswire/ — Thanks to FDA approval of ThyroTest(tm), a new rapid hypothyroid diagnostic screening device from ThyroTec, Inc., detection of a common thyroid disease will now come sooner rather than later for millions of Americans. More Americans suffer from thyroid disease than diabetes and cancer combined.